Cancer Care Business Exchange

The Cancer Care Business Exchange is a high-level, multistakeholder forum that focuses on the business implications of the changing complexities in cancer care delivery and payment.

Cancer Care Business Breakthroughs

News

ONCare Alliance Emerges as a Transformative Force in Independent Oncology and Cancer Care

02/29/2024

Brandon Twyford

Two leading oncology care organizations, the National Cancer Care Alliance (NCCA) and Quality Clinical Cancer Associates (QCCA), have joined forces to create ONCare Alliance, LLC.

Two leading oncology care...

02/29/2024

Cancer Care Business Exchange

Videos

AI in Health Care: Foundations, Myths, and Practical Applications

02/07/2024

Featuring Ira Klein, MD, MBA

Ira Klein, MD, MBA, vice president of medical affairs for Tempus Labs, provides insight into the future of AI in health care and how it will help cut down on mundane tasks and increase oncologists’ efficiency.

Ira Klein, MD, MBA, vice...

02/07/2024

Journal of Clinical Pathways

Videos

Insights from CPC+CBEx 2023

01/18/2024

Featuring John Hennessy, MBA

John Hennessy, MBA, details his highlights from CPC+CBEx 2023 and answers questions related to cancer care, industry consolidation, and the future of cancer care at home.

John Hennessy, MBA, details his...

01/18/2024

Journal of Clinical Pathways

Todd Schonherz, American Oncology Network

Videos

Healthcare Industry Consolidation And What This Means For Community Oncology Practices

11/21/2023

Featuring Todd Schonherz

Todd Schonherz, CEO of American Oncology Network, details his session on the impact that industry consolidation has had on community oncology practices at CPC+CBEx 2023.

Todd Schonherz, CEO of American...

11/21/2023

Journal of Clinical Pathways

Conference Coverage

CPC & CBEx Session Preview: Updates from Washington, Healthcare Industry Consolidation, and Cancer Care at Home

10/03/2023

Featuring Barbara McAneny, MD

CPC & CBEx faculty member Barbara McAneny, MD, gives a preview of her three featured sessions from the conference, including key points on health care industry consolidation, legislative updates, and important considerations for delivering...

CPC & CBEx faculty member...

10/03/2023

Journal of Clinical Pathways

Videos

Care Management Programs vs Value-Based Programs: The Path Forward

09/28/2023

Featuring Barry Russo, MBA; Brandy Manning, MSN, RN, OCN; Amy Valley, PharmD; and Tanya Park

Featuring Barry Russo, MBA; Brandy Ma...

In this Cancer Care Business Breakthroughs, Barry Russo, MBA, spoke with Brandy Manning, MSN, RN, OCN; Amy Valley, PharmD; and Tanya Park about why many oncology practices opted out of the Enhancing Oncology Model and what tools and resources...

In this Cancer Care Business...

09/28/2023

Cancer Care Business Exchange

Videos

Scaling Precision Medicine Expertise for Equitable Cancer Care: Breaking Barriers, Advancing Patient Outcomes

09/08/2023

Featuring James Hamrick, MD, MPH

Featuring James Hamrick, MD, MPH ...

In this video, James Hamrick, MD, MPH, Flatiron Health, previews his session at CPC + CBEx in October on the importance of precision medicine in delivering equitable cancer care.

In this video, James Hamrick,...

09/08/2023

Cancer Care Business Exchange

Videos

Biosimilars, Explained

08/28/2023

Featuring John Hennessy, MBA

John Hennessy, MBA, Valuate Health Consultancy, explains biosimilars in relation to cancer care: what they are, why they matter, and how they have and haven’t lived up to their promise.

John Hennessy, MBA, Valuate...

08/28/2023

Cancer Care Business Exchange

Videos

Cancer Care at Home: Opportunities, Risks, and How to Prepare

08/18/2023

Featuring John Hennessy, MBA

CBEx Advisory Board Member John Hennessy, MBA, Valuate Health Consultancy, previews his featured CPC+CBEx meeting session, “Cancer Care at Home: Opportunities, Risks, and How to Prepare.”

CBEx Advisory Board Member John...

08/18/2023

Cancer Care Business Exchange

Videos

“Treating the Person: Integrating Support Services into Clinical Pathways” at the Clinical Pathways Congress with the Cancer Care Business Exchange

08/11/2023

Mary Cooley, PhD, Dana-Farber Cancer Institute, and David Lobach, MD, Elimu Informatics, provide an inside look into their CPC session “Treating the Person: Integrating Support Services into Clinical Pathways.”

Mary Cooley, PhD, Dana-Farber...

08/11/2023

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Recent Stories

Breaking Down Health Care

Why People Should Care About How Health Care Works (Part 1)

07/29/2024

Michael Kolodziej , MD;

John Hennessy , MBA;

In part one of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dive into the topic of big data: what it is, how it came about, and why we’re still struggling to leverage it.

In part one of this two-part...

07/29/2024

Cancer Care Business Exchange

Breaking Down Health Care

Show Me the Medical Evidence

07/15/2024

Michael Kolodziej , MD;

John Hennessy , MBA;

In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, talk about the challenges of practicing medicine and keeping up with treatment developments when the evidence is constantly changing and evolving.

In this Breaking Down Health...

07/15/2024

Cancer Care Business Exchange

Breaking Down Health Care

What Does Quality Mean in Health Care?

07/01/2024

Michael Kolodziej , MD;

John Hennessy , MBA;

In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, examine how to measure quality in health care and the current challenges with the existing methods.

In this Breaking Down Health...

07/01/2024

Cancer Care Business Exchange

Breaking Down Health Care

The Balance Between Drug Safety and Availability

06/17/2024

Michael Kolodziej, MD

John Hennessy, MBA

In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the process of drug approvals and the role of the US Food and Drug Administration, including how and why the process takes so much time—and...

In this Breaking Down Health...

06/17/2024

Cancer Care Business Exchange

Breaking Down Health Care

Medicare for All: Careful What You Wish for

06/03/2024

Michael Kolodziej, MD

John Hennessy, MBA

In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dive into the topic of Medicare for All and universal health care: why these terms are not interchangeable, and if they could actually solve the...

In this Breaking Down Health...

06/03/2024

Cancer Care Business Exchange

Cancer Care Business Exchange

Current Issue

Special Reports

Subscribe

Recent Stories

Specialties

Events

Year Round Education

HMP Global Products